AN2690

DRUG4 trials

Sponsors

Pfizer

Conditions

Onychomycosis

Phase 1

Cumulative Irritation Test

CompletedNCT00680095

PfizerOnychomycosis

Start: 2007-01-22End: 2007-02-19Updated: 2019-04-09

Phase 2

Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I)

CompletedNCT00680160

PfizerOnychomycosis

Start: 2006-04-30End: 2007-05-09Updated: 2019-02-21

Safety and Efficacy Evaluation of Topically Applied AN2690 Solutions for Subjects With Onychomycosis

CompletedNCT00680134

PfizerOnychomycosis

Start: 2006-06-30End: 2007-08-31Updated: 2018-02-20

Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II)

CompletedNCT00679601

PfizerOnychomycosis

Start: 2007-03-31End: 2007-05-31Updated: 2018-02-20